The eagle-like effect of echinocandins: what’s in a name?

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.

Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638 · see citing works

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A. P., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. A., & Boyd, M. R. (1988) · PubMed · Cited by 2,342 · see citing works

Biofilm Formation by the Fungal Pathogen <i>Candida albicans</i> : Development, Architecture, and Drug Resistance

Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · see citing works

Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052 · see citing works

Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi

Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works

Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard

Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 695 · see citing works

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638 · see citing works

Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins

Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · see citing works

Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents

Baillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389 · see citing works

THE RATE OF BACTERICIDAL ACTION OF PENICILLIN IN VITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMS

Eagle, H., & Musselman, A. D. (1948) · The Journal of Experimental Medicine · doi:10.1084/jem.88.1.99 · Cited by 378 · see citing works

Echinocandin Antifungal Drugs in Fungal Infections: A Comparison

Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371 · see citing works

Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism

Kuhn, D. M., Balkis, M. M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.506-508.2003 · Cited by 339 · see citing works

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

Kurtz, M., Heath, I. B., Marrinan, J. A., Dreikorn, S., Onishi, J. C., & Douglas, C. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1480 · Cited by 321 · see citing works

The PKC, HOG and Ca ²⁺ signalling pathways co‐ordinately regulate chitin synthesis in <i>Candida albicans</i>

Munro, C. A., Selvaggini, S., De Bruijn, I., Walker, L., Lenardon, M. D., Gerssen, B., Milne, S., Brown, A. J. P., & Gow, N. A. R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05588.x · Cited by 309 · see citing works

Caspofungin

Saravolatz, L. D., Deresinski, S. C., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/375080 · Cited by 295 · see citing works

Experimental approach to the problem of treatment failure with penicillin

Eagle, H. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90293-3 · Cited by 279 · see citing works

Comparison of NCCLS and 3-(4,5-Dimethyl-2-Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method

Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Donnelly, J. P., & Verweij, P. E. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.2949-2954.2000 · Cited by 245 · see citing works

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Seibel, N. L., Schwartz, C. L., Arrieta, A. C., Flynn, P. M., Shad, A. T., Albano, E., Keirns, J. J., Lau, W. M., Facklam, D., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 241 · see citing works

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C. L., Shad, A. T., Kaplan, S. L., Roden, M. M., Stone, J. A., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4536-4545.2005 · Cited by 238 · see citing works

In Vitro Pharmacodynamic Properties of Three Antifungal Agents against PreformedCandida albicansBiofilms Determined by Time-Kill Studies

Ramage, G., VandeWalle, K., Bachmann, S. P., Wickes, B. L., & Lopez-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3634-3636.2002 · Cited by 238 · see citing works

Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations

Stevens, D. A., Espiritu, M., & Parmar, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3407-3411.2004 · Cited by 218 · see citing works

Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin

Walker, L. A., Gow, N. A. R., & Munro, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-12 · Cited by 214 · see citing works

A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

Betts, R. F., Nucci, M., Talwar, D., Gareca, M., Queiroz‐Telles, F., Bedimo, R. J., Herbrecht, R., Ruiz‐Palacios, G., Young, J. H., Baddley, J. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598933 · Cited by 214 · see citing works

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Benjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 209 · see citing works

Nalidixic Acid: an Antibacterial Paradox

Crumplin, G. C., & Smith, J. T. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.251 · Cited by 197 · see citing works

Escape of <i>Candida</i> from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by Caspofungin

Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193 · see citing works

Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

Petraitienė, R., Petraitis, V., Groll, A. H., Sein, T., Schaufele, R. L., Francesconi, A., Bacher, J., Avila, N. A., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.12-23.2002 · Cited by 182 · see citing works

The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants

Heresi, G. P., Gerstmann, D. R., Reed, M. D., van den Anker, J. N., Blumer, J. L., Kovanda, L. L., Keirns, J. J., Buell, D. N., & Kearns, G. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000245103.07614.e1 · Cited by 178 · see citing works

Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L. B., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 177 · see citing works

Paradoxical Effect of Echinocandins across <i>Candida</i> Species In Vitro: Evidence for Echinocandin-Specific and <i>Candida</i> Species-Related Differences

Chamilos, G., Lewis, R. E., Albert, N., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00095-07 · Cited by 171 · see citing works

Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus Species

Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Donnelly, J. P., Verweij, P. E., & EUROFUNG Network (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3402-3408.2001 · Cited by 162 · see citing works

Differential Effects of Inhibiting Chitin and 1,3-β- <scp>d</scp> -Glucan Synthesis in Ras and Calcineurin Mutants of <i>Aspergillus fumigatus</i>

Fortwendel, J. R., Juvvadi, P. R., Pinchai, N., Perfect, B. Z., Alspaugh, J. A., Perfect, J. R., & Steinbach, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01154-08 · Cited by 161 · see citing works

Transcriptional Regulation of Chitin Synthases by Calcineurin Controls Paradoxical Growth of <i>Aspergillus fumigatus</i> in Response to Caspofungin

Fortwendel, J. R., Juvvadi, P. R., Perfect, B. Z., Rogg, L. E., Perfect, J. R., & Steinbach, W. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00854-09 · Cited by 153 · see citing works

Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin

Jiménez-Garrido, N., Perelló, L., Ortiz, R., Alzuet, G., González‐Álvarez, M., Cantón, R., Liu‐González, M., García‐Granda, S., & Pérez-Priede, M. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.11.016 · Cited by 152 · see citing works

Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant

Hiemenz, J., Cagnoni, P. J., Simpson, D., Devine, S. M., Chao, N. J. A., Keirns, J. J., Lau, W. M., Facklam, D., & Buell, D. N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1331-1336.2005 · Cited by 150 · see citing works

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1313 · Cited by 144 · see citing works

The yeast cell-wall salvage pathway

Popolo, L., Gualtieri, T., & Ragni, E. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.111.121 · Cited by 142 · see citing works

Comparison of a 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H -Tetrazolium Hydroxide (XTT) Colorimetric Method with the Standardized National Committee for Clinical Laboratory Standards Method of Testing Clinical Yeast Isolates for Susceptibility to Antifungal Agents

Hawser, S., Norris, H. A., Jessup, C. J., & Ghannoum, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1450-1452.1998 · Cited by 140 · see citing works

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

Spriet, I., Annaert, P., Meersseman, P., Hermans, G., Meersseman, W., Verbesselt, R., & Willems, L. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp026 · Cited by 140 · see citing works

Immunocompromised Hosts: Immunopharmacology of Modern Antifungals

Ben‐Ami, R., Lewis, R. E., & Kontoyiannis, D. P. (2008) · Clinical Infectious Diseases · doi:10.1086/589290 · Cited by 140 · see citing works

Heat Shock Protein 90 Is Required for Conidiation and Cell Wall Integrity in Aspergillus fumigatus

Lamoth, F., Juvvadi, P. R., Fortwendel, J. R., & Steinbach, W. J. (2012) · Eukaryotic Cell · doi:10.1128/ec.00032-12 · Cited by 136 · see citing works

Attenuation of the Activity of Caspofungin at High Concentrations against <i>Candida albicans</i> : Possible Role of Cell Wall Integrity and Calcineurin Pathways

Wiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5146-5148.2005 · Cited by 131 · see citing works

Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin

Kucharíková, S., Tournu, H., Lagrou, K., Dijck, P. V., & Bujdáková, H. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.032037-0 · Cited by 122 · see citing works

Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

Petraitis, V., Petraitienė, R., Groll, A. H., Bell, A., Callender, D. P., Sein, T., Schaufele, R. L., McMillian, C. L., Bacher, J. D., & Walsh, T. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2898 · Cited by 118 · see citing works

Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit

Nguyen, T. H., Hoppe‐Tichy, T., Geiss, H. K., Rastall, A. C., Swoboda, S., Schmidt, J., & Weigand, M. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm125 · Cited by 118 · see citing works

Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida Species

Melo, A. S. D. A., Colombo, A. L., & Arthington, B. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00676-07 · Cited by 117 · see citing works

Susceptibility of Pathogenic Actinomycetes to Antimicrobial Compounds

Lerner, P. I. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.5.3.302 · Cited by 108 · see citing works

Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine

Dowell, J. A., Stogniew, M., Krause, D., Henkel, T. J., & Weston, I. E. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004270146 · Cited by 106 · see citing works

Studies of the paradoxical effect of caspofungin at high drug concentrations

Stevens, D. A., White, T. C., Perlin, D. S., & Selitrennikoff, C. P. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.10.006 · Cited by 103 · see citing works

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

Gauthier, G. M., Nork, T. M., Prince, R., & Andes, D. (2005) · Clinical Infectious Diseases · doi:10.1086/431761 · Cited by 99 · see citing works

Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

Clemons, K. V., Espiritu, M., Parmar, R., & Stevens, D. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1293-1297.2006 · Cited by 99 · see citing works

In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth

Cateau, E., Rodier, M.-H., & Imbert, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn160 · Cited by 98 · see citing works

In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J. S., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01155-09 · Cited by 98 · see citing works

Changes in Cell Wall Synthesis and Ultrastructure during Paradoxical Growth Effect of Caspofungin on Four Different Candida Species

Bizerra, F. C., Melo, A. S. D. A., Katchburian, E., Freymüller, E. H., Straus, A. H., Takahashi, H. K., & Colombo, A. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-10 · Cited by 92 · see citing works

Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin

Diver, J. M., & Wise, R. A. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.31 · Cited by 92 · see citing works

<i>In Vitro</i> Activity of Calcineurin and Heat Shock Protein 90 Inhibitors against Aspergillus fumigatus Azole- and Echinocandin-Resistant Strains

Lamoth, F., Juvvadi, P. R., Gehrke, C., & Steinbach, W. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01857-12 · Cited by 88 · see citing works

Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis

Fleischhacker, M., Radecke, C., Schulz, B., & Ruhnke, M. (2008) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-007-0411-4 · Cited by 78 · see citing works

Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli

Piddock, L. J. V., Walters, R. N., & Diver, J. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2331 · Cited by 78 · see citing works

Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Neely, M. N., Jafri, H. S., Seibel, N. L., Knapp, K. M., Adamson, P. C., Bradshaw, S. K., Strohmaier, K. M., Sun, P. G., Bi, S., Dockendorf, M. F., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01027-08 · Cited by 76 · see citing works

Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia

Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., & Walsh, T. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00699-07 · Cited by 76 · see citing works

Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

Cohen‐Wolkowiez, M., Benjamin, D. K., Piper, L., Cheifetz, I. M., Moran, C., Liu, P., Aram, J. A., Kashuba, A. D. M., Capparelli, E. V., Walsh, T. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.26 · Cited by 73 · see citing works

Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis

Hall, G. S., Myles, C., Pratt, K., & Washington, J. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1331 · Cited by 67 · see citing works

Action of Penicillin on Bacteria

Garrod, L. P. (1945) · BMJ · doi:10.1136/bmj.1.4386.107 · Cited by 67 · see citing works

BACTERIOSTATIC AND LYTIC ACTIONS OF PENICILLIN ON SENSITIVE AND RESISTANT STAPHYLOCOCCI 1

Kirby, W. M. M. (1945) · Journal of Clinical Investigation · doi:10.1172/jci101593 · Cited by 67 · see citing works

Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis

Liu, P., Ruhnke, M., Meersseman, W., Paiva, J. A., Kantecki, M., & Damle, B. D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02139-12 · Cited by 67 · see citing works

Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum

Shields, R. K., Nguyen, M. H., Du, C., Press, E., Cheng, S., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-10 · Cited by 65 · see citing works

Single‐ and Multiple‐Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations

Mistry, G. C., Migoya, E. M., Deutsch, P., Winchell, G. A., Hesney, M., Li, S., Bi, S., Dilzer, S. C., Lasseter, K. C., & Stone, J. A. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007303764 · Cited by 64 · see citing works

Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect

Wiederhold, N. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f1be7f · Cited by 64 · see citing works

Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy

Weiler, S., Seger, C., Pfisterer, H., Stienecke, E., Stippler, F., Welte, R., Joannidis, M., Griesmacher, A., & Bellmann, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00335-13 · Cited by 60 · see citing works

Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species

Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01160-06 · Cited by 56 · see citing works

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

Lewis, R. E., Albert, N. D., & Kontoyiannis, D. P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn069 · Cited by 56 · see citing works

Paradoxical Increase in Circulating Aspergillus Antigen during Treatment with Caspofungin in a Patient with Pulmonary Aspergillosis

Klont, R. R., Mennink‐Kersten, M. A. S. H., Ruegebrink, D., Rijs, A. J. M. M., Blijlevens, N. M. A., Donnelly, J. P., & Verweij, P. E. (2006) · Clinical Infectious Diseases · doi:10.1086/505603 · Cited by 49 · see citing works

Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults

Crandon, J. L., Banevicius, M. A., Fang, A. F., Crownover, P. H., Knauft, R. F., Pope, J. S., Russomanno, J. H., Shore, E. T., Nicolau, D. P., & Kuti, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01042-09 · Cited by 48 · see citing works

Paradoxical echinocandin activity: a limitedin vitrophenomenon?

Wiederhold, N. P. (2009) · Medical Mycology · doi:10.1080/13693780802428542 · Cited by 48 · see citing works

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration

Leitner, J. M., Meyer, B., Fuhrmann, V., Saria, K., Zuba, C., Jäger, W. R., Böhmdorfer, M., & Thalhammer, F. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq545 · Cited by 47 · see citing works

Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients

Groll, A. H., Silling, G., Young, C., Schwerdtfeger, R., Ostermann, H., Heinz, W., Gerß, J., Kolve, H., Lanvers‐Kaminsky, C., Pinheiro, J. P. V., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-10 · Cited by 44 · see citing works

Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests

Jahn, B., Stüben, A., & Bhakdi, S. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.8.2039-2041.1996 · Cited by 44 · see citing works

Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections

Tabata, K., Katashima, M., Kawamura, A., Tanigawara, Y., & Sunagawa, K. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1706 · Cited by 43 · see citing works

Steady-State Pharmacokinetics of Micafungin and Voriconazole after Separate and Concomitant Dosing in Healthy Adults

Keirns, J. J., Sawamoto, T., Holum, M. E., Buell, D. N., Wisemandle, W., & Alak, A. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00673-06 · Cited by 43 · see citing works

Activities of Systemically Administered Echinocandins against In Vivo Mature Candida albicans Biofilms Developed in a Rat Subcutaneous Model

Kucharíková, S., Sharma, N., Spriet, I., Maertens, J. A., Dijck, P. V., & Lagrou, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02288-12 · Cited by 43 · see citing works

FURTHER OBSERVATIONS ON THE ZONE PHENOMENON IN THE BACTERICIDAL ACTION OF PENICILLIN

Eagle, H. (1951) · Journal of Bacteriology · doi:10.1128/jb.62.5.663-668.1951 · Cited by 41 · see citing works

Bactericidal Action of Streptomycin

Garrod, L. P. (1948) · BMJ · doi:10.1136/bmj.1.4547.382 · Cited by 40 · see citing works

Pharmacokinetics of Micafungin in Pediatric Patients With Invasive Candidiasis and Candidemia

Undre, N. A., Stevenson, P., Freire, A., & Arrieta, A. C. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31824ab9b0 · Cited by 37 · see citing works

Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia

Huang, L., Zhang, Y. Y., & Sun, L. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1826-8 · Cited by 36 · see citing works

Biphasic kinetics of bacterial killing by quinolones

Carret, G., Flandrois, J., & Lobry, J. R. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.3.319 · Cited by 35 · see citing works

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

Migoya, E. M., Mistry, G. C., Stone, J. A., Comisar, W. A., Sun, P. G., Norcross, A., Bi, S., Winchell, G. A., Ghosh, K., Uemera, N., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010374853 · Cited by 31 · see citing works

Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers

Nicasio, A. M., Tessier, P. R., Nicolau, D. P., Knauft, R. F., Russomanno, J. H., Shore, E. T., & Kuti, J. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01386-08 · Cited by 31 · see citing works

Inhibitory and Fungicidal Effects of Antifungal Drugs against Aspergillus Species in the Presence of Serum

Elefanti, A., Mouton, J. W., Krompa, K., Al‐Saigh, R., Verweij, P. E., Zerva, L., & Meletiadis, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01573-12 · Cited by 28 · see citing works

Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach

Bašková, L., & Buchta, V. (2012) · Folia Microbiologica · doi:10.1007/s12223-012-0152-3 · Cited by 27 · see citing works

Candida albicans and Candida dubliniensis Respond Differently to Echinocandin Antifungal Agents In Vitro

Jacobsen, M. D., Whyte, J. A., & Odds, F. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-06 · Cited by 27 · see citing works

Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials

Irwin, N., McCoy, C. P., & Carson, L. (2013) · Journal of Applied Microbiology · doi:10.1111/jam.12241 · Cited by 26 · see citing works

Pharmacokinetics of Anidulafungin in Pleural Fluid during the Treatment of a Patient with Candida Empyema

Moriyama, B., Ditullio, M., Wilson, E. M. P., Henning, S. A., Penzak, S. R., Danner, R. L., Pennick, G. J., Rinaldi, M. G., Zelazny, A. M., Gea‐Banacloche, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01560-10 · Cited by 26 · see citing works

Role of Innate Immune Receptors in Paradoxical Caspofungin ActivityIn Vivoin Preclinical Aspergillosis

Moretti, S., Bozza, S., D'Angelo, C., Casagrande, A., Fazia, M. A. D., Pitzurra, L., Romani, L. R., & Aversa, F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05198-11 · Cited by 24 · see citing works

Micafungin Concentrations from Brain Tissue and Pancreatic Pseudocyst Fluid

Lat, A., Thompson, G. R., Rinaldi, M. G., Dorsey, S. A., Pennick, G. J., & Lewis, J. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01294-09 · Cited by 24 · see citing works

Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds

Stevens, P. J. E. (1980) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/6.4.535 · Cited by 23 · see citing works

The Effects of an Hsp90 Inhibitor on the Paradoxical Effect

Kaneko, Y., Ohno, H., Imamura, Y., Kohno, S., & Miyazaki, Y. (2009) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2009.392 · Cited by 23 · see citing works

Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis

Spriet, I., Meersseman, W., Annaert, P., Hoon, J. N. J. M. D., & Willems, L. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1066-8 · Cited by 22 · see citing works

Successful Micafungin (FK463) Treatment of Invasive Pulmonary Aspergillosis in a Patient with Acute Lymphoblastic Leukemia in a Phase II Study

Ota, S., Tanaka, J., Kahata, K., Toubai, T., Kondo, K., Mori, A., Toyoshima, N., Musashi, M., Asaka, M., & Imamura, M. (2004) · International Journal of Hematology · doi:10.1532/ijh97.03163 · Cited by 22 · see citing works

Killing Kinetics of Four Quinolones against Gram-Positive Cocci

Cantón, R., Ramon, M. S., Jimenez, M. T., & Martinez, J. P. (2009) · Chemotherapy · doi:10.1159/000238983 · Cited by 21 · see citing works

Paradoxical effect of antibiotics

SHAH, P. M. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/10.4.259 · Cited by 21 · see citing works

Intraocular Penetration of Micafungin in Patient with Candida albicans Endophthalmitis

Mochizuki, K., Suemori, S., Udo, K., Komori, S., Ohkusu, K., Yamada, N., & Ogura, S. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0026 · Cited by 21 · see citing works

In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms

Miceli, M. H., Bernardo, S. M., & Lee, S. A. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.07.001 · Cited by 21 · see citing works

In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin

Bayegan, S., Majoros, L., Kardos, G., Kemény-Beke, A., Miszti, C., Kovacs, R., & Gesztelyi, R. (2010) · The Journal of Microbiology · doi:10.1007/s12275-010-9221-y · Cited by 21 · see citing works

Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin Therapy

Mariné, M., Pastor, F. J., Sahand, I. H., Pontón, J., Quindós, G., & Guarro, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00980-09 · Cited by 20 · see citing works

Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin againstCandida speciesusing time-kill methodology

Szilágyi, J., Földi, R., Bayegan, S., Kardos, G., & Majoros, L. (2012) · Journal of Chemotherapy · doi:10.1179/1120009x12z.0000000005 · Cited by 18 · see citing works

Five-Minute Exposure to Caspofungin Results in Prolonged Postantifungal Effects and Eliminates the Paradoxical Growth of Candida albicans

Shields, R. K., Nguyen, M. H., Press, E. G., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00095-11 · Cited by 18 · see citing works

Micafungin Concentrations in the Plasma and Burn Eschar of Severely Burned Patients

Sasaki, J., Yamanouchi, S., Kudo, D., Endo, T., Nomura, R., Takuma, K., Kushimoto, S., Shinozawa, Y., Kishino, S., Hori, S., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05381-11 · Cited by 16 · see citing works

In-vitro activity of pefloxacin compared to other antibiotics

Yourassowsky, E., van der Linden, M., Crokaert, F., & Glupczynski, Y. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/17.suppl_b.19 · Cited by 16 · see citing works

Plasma concentration of micafungin in patients with hematologic malignancies

Nakagawa, Y., Suzuki, K., Ichii, Y., Saeki, Y., Kodaka, M., & Kishino, S. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0496-1 · Cited by 16 · see citing works

Paradoxical effect of antibiotics

Annear, D. I. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/10.4.260 · Cited by 15 · see citing works

In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms

Ku, T. S. N., Bernardo, S. M., & Lee, S. A. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.032235-0 · Cited by 13 · see citing works

Immunological Aspects ofCandidaandAspergillusSystemic Fungal Infections

Mueller-Loebnitz, C., Ostermann, H., Franzke, A., Loeffler, J., Uharek, L., Topp, M. S., & Einsele, H. (2013) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2013/102934 · Cited by 13 · see citing works

Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction

van der Elst, K. C. M., Brüggemann, R. J. M., Rodgers, M. G. G., & Alffenaar, J. C. (2012) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00716.x · Cited by 13 · see citing works

Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood

Farowski, F., Cornely, O. A., Vehreschild, J. J., Bauer, T., Hartmann, P., Steinbach, A., Vehreschild, M. J. G. T., Scheid, C., & Müller, C. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.006 · Cited by 13 · see citing works

Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method

Pai, M. P., Jones, A. L., & Mullen, C. K. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.017 · Cited by 12 · see citing works

High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis

Burkhardt, O., Ellis, S., Burhenne, H., Kaever, V., Hadem, J., Kielstein, J. T., & Welte, T. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.04.002 · Cited by 11 · see citing works

Pharmacokinetics of Caspofungin in Two Patients with Burn Injuries

Jullien, V., Blanchet, B., Benyamina, M., Tod, M. M., & Vinsonneau, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-12 · Cited by 9 · see citing works

Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin

Yourassowsky, E., van der Linden, M., Lismont, M. J., Crokaert, F., & Glupczynski, Y. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.2.258 · Cited by 5 · see citing works

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

Bellmann, R., & Smuszkiewicz, P. (2017) · Infection · doi:10.1007/s15010-017-1042-z · Cited by 399 · see citing works

Echinocandins – structure, mechanism of action and use in antifungal therapy

Szymański, M., Chmielewska, S., Czyżewska, U., Malinowska, M., & Tylicki, A. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2050224 · Cited by 281 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Echinocandins in antifungal pharmacotherapy

Patil, A., & Majumdar, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12780 · Cited by 145 · see citing works

Fungal persister cells: The basis for recalcitrant infections?

Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136 · see citing works

Antifungal Pharmacokinetics and Pharmacodynamics

Lepak, A. J., & Andes, D. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019653 · Cited by 134 · see citing works

Sources of Antifungal Drugs

Vanreppelen, G., Wuyts, J., Dijck, P. V., & Vandecruys, P. (2023) · Journal of Fungi · doi:10.3390/jof9020171 · Cited by 112 · see citing works

The eagle effect and antibiotic-induced persistence: two sides of the same coin?

Prasetyoputri, A., Jarrad, A. M., Cooper, M. A., & Blaskovich, M. A. T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.10.007 · Cited by 101 · see citing works

Antifungal Susceptibility Testing: A Primer for Clinicians

Wiederhold, N. P. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab444 · Cited by 80 · see citing works

Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS

Vatanshenassan, M., Boekhout, T., Meis, J. F. G. M., Berman, J. G., Chowdhary, A., Ben‐Ami, R., Sparbier, K., & Kostrzewa, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00020 · Cited by 66 · see citing works

In vitro antibacterial effects of statins against bacterial pathogens causing skin infections

Ko, H. H. T., Lareu, R. R., Dix, B. R., & Hughes, J. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3227-5 · Cited by 57 · see citing works

Molecular characterisation of <i>Candida auris</i> isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in <i>FKS1</i> conferring reduced susceptibility to echinocandins

Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55 · see citing works

The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1

Loiko, V., & Wagener, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01690-16 · Cited by 51 · see citing works

In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.

Franconi, I., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9121188 · Cited by 37 · see citing works

A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients

Brüggemann, R. J. M., van der Velden, W. J. F. M., Knibbe, C. A. J., Colbers, A. P. H., Hol, S., Burger, D. M., Donnelly, J. P., & Blijlevens, N. M. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku477 · Cited by 28 · see citing works

Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance

Binder, U., Aigner, M., Risslegger, B., Hörtnagl, C., Lass‐Flörl, C., & Lackner, M. (2019) · Journal of Fungi · doi:10.3390/jof5030083 · Cited by 19 · see citing works

Pharmacokinetics of extended dose intervals of micafungin in haematology patients: optimizing antifungal prophylaxis

Muilwijk, E. W., Maertens, J. A., van der Velden, W. J. F. M., ter Heine, R., Colbers, A. P. H., Burger, D. M., Andes, D. R., Theunissen, K., Blijlevens, N. M. A., & Brüggemann, R. J. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky324 · Cited by 17 · see citing works

Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia

Marcos-Zambrano, L. J., Escribano, P., Sánchez‐Carrillo, C., Bouza, E., & Guinea, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01584-16 · Cited by 16 · see citing works

Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage

Pirofski, L., & Casadevall, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01800-19 · Cited by 15 · see citing works

Antifungal persistence: Clinical relevance and mechanisms

Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12 · see citing works

Aneuploidy underlies paradoxical growth of rezafungin and enables cross-tolerance to echinocandins in Candida albicans

Li, H., Cao, Y., Yan, T., Jiang, Y., & Yang, F. J. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.09.028 · Cited by 7 · see citing works

Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins

Kordalewska, M., & Perlin, D. S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_6 · Cited by 5 · see citing works

Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China

Lin, W., Peng, Y., Xiang, B., Fang, J., Ye, J., & Guo, P. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04275-y · Cited by 3 · see citing works

Combined Effect of Platelets and Anidulafungin against Aspergillus fumigatus Infections

Schiefermeier Mach, N., Bellmann, R., Fréalle, É., & Perkhofer, S. (2017) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000334 · Cited by 2 · see citing works

Human and murine Cryptococcus neoformans infection selects for common genomic changes in an environmental isolatePreprint

Sephton-Clark, P., McConnell, S. A., Grossman, N. T., Baker, R. P., Dragotakes, Q., Fan, Y., Fu, M. S., Gerbig, G. R., Greengo, S. D., Hardwick, J. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.487930 · Cited by 2 · see citing works

FIRST REPORT OF CANDIDA AURIS IN VIETNAMPreprint

Truong-Thien, P., Tuan, A. N., & Nguyen, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.12.653631

Antibacterial Potential of Lucilia sericata (Meigen, 1826) (Diptera: Calliphoridae) Maggot Excretions/Secretions in Presence of Human Tear Fluid

Owusu, E., Savani, S., & Redfern, R. L. (2025) · Neotropical Entomology · doi:10.1007/s13744-025-01306-1

The catheterized urinary tract selects for MRR1 -mediated efflux and fluconazole resistance in Candida albicans biofilms

Cristy, S. A., Walker, J. N., & Lorenz, M. C. (2026) · mBio · doi:10.1128/mbio.01785-26

The Eagle-Like Effect of the Echinocandins: Is It Relevant for Clinical Decisions?

Stover, K. R., & Cleary, J. D. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-015-0221-6 · Cited by 8 · see citing works

Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect

Wiederhold, N. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f1be7f · Cited by 64 · see citing works

Paradoxical echinocandin activity: a limitedin vitrophenomenon?

Wiederhold, N. P. (2009) · Medical Mycology · doi:10.1080/13693780802428542 · Cited by 48 · see citing works

Echinocandin pharmacodynamics: review and clinical implications

Pound, M. W., Townsend, M. L., & Drew, R. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq081 · Cited by 69 · see citing works

Recent Insights into the Paradoxical Effect of Echinocandins

Wagener, J., & Loiko, V. (2017) · Journal of Fungi · doi:10.3390/jof4010005 · Cited by 73 · see citing works